GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,461.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 1,766.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,098.64m
  • Volume: 260,757
  • Market Cap: £59,881m
  • RiskGrade: 129
  • Beta: 0.00

Pharma stocks slide as Trump threatens price cuts in US

By Frank Prenesti

Date: Monday 12 May 2025

LONDON (ShareCast) - (Sharecast News) - Shares in pharmaceutical companies fell on Monday after US President Donald Trump threatened to sign an executive order to slash the price of prescription drugs for Americans.
Trump said he would sign an order on Monday to cut prescription drug and pharmaceutical prices "almost immediately" by "30% to 80%".

"The Pharmaceutical/Drug Companies would say, for years, that it was Research and Development Costs, and that all of these costs were, and would be, for no reason whatsoever, borne by the "suckers" of America, ALONE," he wrote on social media on Sunday.

He added that it was "difficult to explain and very embarrassing" why US prices were higher compared with other countries and that he would introduce a "most favoured nation" policy, where the US pays "the same price as the nation that pays the lowest price anywhere in the World".

Shares in pharma companies around the world were lower on the news, with AstraZeneca, GSK, Novo Nordisk, Roche, Sanofi, Sandoz and Haleon were all hit.

Reporting by Frank Prenesti for Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,461.00p
Change Today 5.00p
% Change 0.34 %
52 Week High 1,766.50
52 Week Low 1,264.00
Volume 260,757
Shares Issued 4,098.64m
Market Cap £59,881m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.42% below the market average45.42% below the market average45.42% below the market average45.42% below the market average45.42% below the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average
Price Trend
18.04% above the market average18.04% above the market average18.04% above the market average18.04% above the market average18.04% above the market average
43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average
Income
74.28% above the market average74.28% above the market average74.28% above the market average74.28% above the market average74.28% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
36.99% below the market average36.99% below the market average36.99% below the market average36.99% below the market average36.99% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 30-May-2025

Time Volume / Share Price
08:21 0 @ 1,461.00p
08:22 442 @ 1,461.00p
08:22 431 @ 1,461.00p
08:22 1,412 @ 1,461.00p
08:22 600 @ 1,460.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page